|
시장보고서
상품코드
2049517
투시 장비 시장 보고서 : 장비 유형별, 용도별, 최종사용자별, 지역별(2026-2034년)Fluoroscopy Equipment Market Report by Equipment Type, Application, End User, and Region 2026-2034 |
||||||
세계의 투시 장비 시장 규모는 2025년에 67억 달러에 달했습니다. 향후 IMARC Group은 2026년부터 2034년까지 CAGR 3.50%를 기록하며 2034년까지 93억 달러에 달할 것으로 예측하고 있습니다.
투시 장비는 X선 소스 어셈블리의 위치 결정을 가능하게 합니다. 일반적으로 콜리메이터, 컴퓨터, X선 튜브, 스펙트럼 성형 필터, 산란 방지 그리드, 이미지 수신기, 디스플레이 장치, 고전압 발생 장치, 환자 지원 장치 및 하드웨어를 이용합니다. 또한, X선 영상 증강관(XRII)과 비디오 카메라를 사용하여 그레이 스케일 반전 이미지를 실시간으로 생성하여 역동적인 생물학적 과정을 평가하고 치료의 지침으로 삼습니다. 그 결과 골격, 소화기, 비뇨기, 호흡기, 생식기의 각 구조물의 X선 촬영에 이용되고 있습니다. 다양한 구성으로 제작이 가능하며, 다른 진단 절차와 함께 사용할 수 있습니다.
최신 투시 장비의 감광 기능과 종합적인 효율성을 통해 의료진은 2차 피폭으로부터 보호받을 수 있습니다. 또한 고급 3D 기능을 갖추고 있어 저선량으로 환자의 최소침습(MI) 영상 진단을 가능하게 합니다. 여기에 만성질환의 유병률 증가와 최소침습적 방법에 대한 수요가 크게 증가함에 따라 중재적 방사선학(IR)에 대한 수요가 증가하면서 다양한 진단 검사 및 시술에 투시 장비의 적용 범위가 확대되고 있습니다. 이 외에도 이동식 C-arm 투시 장비는 수술실이나 진료소, 스포츠 의학 분야의 응급의료 분야에서 보급이 진행되고 있습니다. 또한, 주요 제조업체들은 가변 프레임 속도, 자동 빔 필터링, 이미지 후처리와 같은 고급 기능을 도입하고 있으며, 이는 향후 몇 년 동안 시장을 주도할 것으로 예상됩니다.
본 보고서에서 답변하는 주요 질문
- 세계 투시 장비 시장은 지금까지 어떤 추세를 보여 왔으며, 향후 몇 년 동안 어떤 추세를 보일 것인가?
- COVID-19는 세계 투시 장비 시장에 어떤 영향을 미쳤는가?
- 주요 지역 시장은 어디인가?
- 장비의 종류별 시장 현황은 어떠한가?
- 용도별 시장 현황은 어떠한가?
- 최종사용자별 시장 현황은 어떠한가?
- 이 산업의 가치사슬에서 각 단계는 어떤 역할을 하는가?
- 이 산업의 주요 촉진요인과 과제는 무엇인가?
- 세계 투시 장비 시장의 구조는 무엇이며, 주요 업체는 누구인가?
- 업계 내 경쟁은 어느 정도 치열한가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 투시 장비 시장
제6장 시장 내역 : 기기 유형별
제7장 시장 내역 : 용도별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KSM 26.06.10The global fluoroscopy equipment market size reached USD 6.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 9.3 Billion by 2034, exhibiting a growth rate (CAGR) of 3.50% during 2026-2034.
Fluoroscopy equipment allows the positioning of the X-ray source assembly. It generally utilizes collimators, computers, X-ray tubes, spectral shaping filters, anti-scatter grids, image receptors, display devices, high-voltage generators, patient-support devices and hardware. It also uses an X-ray image intensifier (XRII) and video camera to produce grayscale inverted images in real-time, thereby evaluating dynamic biological processes and guiding interventions. Consequently, it is used in radiographic imaging of skeletal, digestive, urinary, respiratory, and reproductive body structures. It can be manufactured in a variety of configurations and used in conjunction with other diagnostic procedures.
The amplification and overall efficiency of modern fluoroscopy equipment protect healthcare providers from secondary radiation exposure. It also has advanced 3D capability, which allows minimally invasive (MI) imaging of patients with a low radiation dose. This, along with the escalating need for interventional radiology (IR) on account of the growing prevalence of chronic diseases and a considerable increase in the demand for MI methods, is expanding the application of fluoroscopy equipment in various diagnostic examinations and procedures. Apart from this, mobile C-arm fluoroscopy equipment is gaining traction in surgical suites, and offices and sports medicine for emergency care. Moreover, the key players are introducing advanced features, such as variable frame rate, automatic beam filtration and image post-processing, which is anticipated to drive the market in the coming years.
KEY MARKET SEGMENTATION:
Breakup by Equipment Type:
- Fluoroscopy Devices
- Fixed C-Arms
- Mobile Full Size C-Arms
- Mobile Mini C-Arms
Breakup by Application:
- Orthopedic
- Cardiovascular
- Gastrointestinal
- Urology and Nephrology
- Others
Breakup by End User:
- Hospitals and Specialty Clinics
- Diagnostic Centres
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Adani Systems Inc., Agfa-Gevaert N.V., Canon Medical Systems Corporation, Carestream Health (Onex Corporation), General Electric Company, Hologic Inc., Koninklijke Philips N.V., Shimadzu Corporation, Siemens AG and Ziehm Imaging GmbH.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global fluoroscopy equipment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global fluoroscopy equipment market?
- What are the key regional markets?
- What is the breakup of the market based on the equipment type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global fluoroscopy equipment market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Fluoroscopy Equipment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Equipment Type
- 6.1 Fluoroscopy Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Fixed C-Arms
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Mobile Full Size C-Arms
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Mobile Mini C-Arms
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Application
- 7.1 Orthopedic
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Cardiovascular
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Gastrointestinal
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Urology and Nephrology
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals and Specialty Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Diagnostic Centres
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Adani Systems Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Agfa-Gevaert N.V.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Canon Medical Systems Corporation
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 SWOT Analysis
- 14.3.4 Carestream Health (Onex Corporation)
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.5 General Electric Company
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Hologic Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Koninklijke Philips N.V.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Shimadzu Corporation
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Siemens AG
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Ziehm Imaging GmbH
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.1 Adani Systems Inc.
